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PH Domain Mutation Alters Membrane Targeting Specificity of GRP1
and AKT
Carissa Pilling.
University of Colorado Boulder, Boulder, CO, USA.
Protein kinase B (AKT1) and General Receptor for Phosphoinositides 1
(GRP1) regulate multiple cell signaling pathways essential for cell function
and survival. AKT1 possesses an N-terminal PH domain (AKT1-PH) that binds
important target phosphatidylinositol phospholipids (PIPs) such as PI(3,4)P3
and especially PI(3,4,5)P3. During a signaling event, PI(4,5)P2 gets converted
to PI(3,4,5)P3, resulting in targeting of AKT1 to the cell plasma membrane by
its PH domain. Our recent published work (Landgraf (2008) Biochemistry) re-
vealed that the E17K charge reversal mutation adjacent to the PIP binding site
in AKT1-PH alters the PIP specificity of the site, yielding high affinity binding
to PI(4,5)P2 and constitutive binding to plasma membrane. The resulting hy-
per-activation of AKT1 inhibits apoptosis and explains the known oncogenic
character of the E17K mutation, which is linked to multiple human cancers.
Here we test the hypothesis that glutamate residues often found adjacent to
the PIP binding sites of PI(3,4,5)P3 -specific PH domains are essential to PIP
lipid specificity. Using a combination of biochemical, structural, and cell biol-
ogy approaches, we compare the PIP lipid specificities and intracellular target-
ing of GRP1-PH and E345K-GRP1-PH. The latter mutant possesses a charge
reversal mutation at a glutamate position adjacent to the PIP binding site.
The preliminary findings, which will be presented at the meeting, indicate
that the mutant exhibits high affinity binding to PI(4,5)P2 and constitutive bind-
ing to plasma membrane. These findings support the hypothesis that the adja-
cent glutamate residue plays an essential role in PI(3,4,5)P3 -specificity and
PI(3,4,5)P3 -regulated plasma membrane targeting in cells. Finally, we are in-
vestigating the structural basis for the specificity change by attempting to solve
the crystal structures of the E17K-GRP1-PH and E345K-GRP1-PH mutants
bound to PI(4,5)P2.
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Engineered Nanolipoproteins as Biosynthetic Decoys for Pathogen-
Binding
Atul N. Parikh, Daniel Bricarello, Emily J. Mills, Jitka Petrlova, John Voss.
University of California, UC Davis, CA, USA.
The ability to exogenously present cell-surface receptors in a synthetic system
offers an opportunity to provide host cells with protection from pathogenic
toxins. Practical implementations suffer from serious limitations, primarily be-
cause of difficulties in mimicking the role of the membrane micro-environment
during the complex and dynamic pathogen-receptor interaction. To this end, we
have developed reconstituted lipoprotein - nanometer-sized discoidal lipid bi-
layers of arbitrary composition bounded by apolipoprotein - to serve as a versa-
tile, biocompatible and stable platform to house pathogen-binding receptors in
a membrane-like environment. Our approach exploits the notion that a control
of biophysical properties of the membrane micro-environment allows to mod-
ulate interactions between membrane-embedded receptors and their pathogenic
(e.g., bacterial toxin) targets. We demonstrate here, using a Foerster Resonance
Energy Transfer (FRET) based assay, that ganglioside GM1 receptors incorpo-
rated at controlled concentrations in reconstituted lipoprotein bind cholera
toxin with greater affinity than liposome-based systems. Furthermore, fluores-
cence microscopy investigations of cholera toxin presented to populations of
mammalian cells show that GM1-laden lipoprotein can function as decoys
without harming healthy cells.
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Crystallization of Calcium Carbonate Vaterite Associated with Liquid
Crystal in Embryonic Yolk Sacs
Xuehong Xu1, MengMeng Xu2, Odell Jones3, Guanliang Cao1,
Bryant Joseph3, Guifang Yan4, Chuyu Zhang5.
1University of Maryland Biotechnology Institute, Baltimore, MD, USA,
2University of Maryland Department of Chemistry, College Park, MD, USA,
3University of Maryland School of Medicine, Baltimore, MD, USA, 4Johns
Hopkins University Hospital School of Medicine, Baltimore, MD, USA,
5Wuhan University School of Life Sciences, Wuhan, China.
Calcium carbonate is often used as an efficient antacid that absorbs and neutral-
izes stomach acid while providing calcium for healthy bones. Taking advantage
of the lack of adverse side effects of calcium, new drug delivery systems con-
sisting of drug-supported spherical microparticles are being developed. We
have reported in our previous studies that a natural process producing calcium
carbonate microparticles can be found during avian development. These naturalsystems provide inspiration for designing more efficient microparticle facili-
tated drug-delivery systems. In this study, the formation and re-absorption of
calcium carbonate crystals were tracked during Gallina N. meleagris embryo-
genesis and early postnatal development. The study demonstrated that the for-
mation of calcium carbonate microparticles, as calcium is transferred from the
eggshell into the egg sac, is a process of calcium preservation. X-ray diffraction
showed that calcium carbonate crystal is mainly preserved in the vaterite iso-
form. Calcium incorporated into the yolk sac during this process can be easily
assimilated as necessary during postnatal development. Eons of evolution have
yielded a calcium preservation process that produces an iso-form of crystalline
calcium most readily absorbed by the organism. Our previous results indicate
that this biological system is likely a lyotropic process, the method that is cur-
rently being used for the production of microparticle drug delivery systems. In
this work, our data suggests that calcium carbonate crystal can also initiate its
crystallization from the center of liquid crystal, recognizable by a chimeric
thermal phase transition. Our work provides valuable information for designing
more efficient microparticle for drug-delivery.
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Stim1 Binds to and Inhibits CaV1.2 Voltage Gated Calcium Channels
Chan Young Park, Aleksandr Shcheglovitov, Ricardo E. Dolmetsch.
Stanford, Palo Alto, CA, USA.
CaV1.2 and other L-type voltage gated calcium channels play a key role in reg-
ulating cardiac contraction, synaptic plasticity, insulin secretion and a variety
of other cellular events. Phospho-inositide linked receptors like the muscarinic
acetylcholine receptor, inhibit L-type calcium channels and this inhibition is
important for parasympathetic regulation of heart contraction as well as for
learning and memory in the brain. The mechanisms by which PLC coupled re-
ceptors inhibit L-type channels are still controversial though several hypotheses
including reduction of cAMP and depletion of PIP2 from the cell membrane
have been proposed. We report a new and unexpected mechanism by which
PLC-coupled receptors inhibit L-type calcium channels in cells. We have found
that depletion of ER calcium stores either down stream of muscarinic receptors
or following application of the ER calcium ATPase inhibitor, thapsigargin, in-
hibits CaV1.2 channels. CaV1.2 inhibition depends on binding to Stim1, an ER
calcium sensor protein that activates the Orai family of store operated calcium
channels. In cells expressing CaV1.2, Stim1 translocates to ER-plasma mem-
brane junctions and co-localizes with clusters of CaV1.2. In vitro and in vivo
studies indicate that the CAD domain of Stim1 binds to a coiled coil in the
II-III loop of CaV1.2. Stim1 lacking the CAD domain is unable to bind to
CaV1.2 and fails to inhibit CaV1.2 currents following depletion of ER calcium
stores. These studies support a new mechanism by which phosphoinositide-
linked receptors inhibit L-type calcium channels and suggest that Stim1 dy-
namically regulates the relative contributions of Orai and CaV1.2 channels to
calcium influx in excitable cells.
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Oxygen-Sensing of L-type Calcium Channels in Rat Cardiomyocytes: The
Possible Role of Hemoxygenase
Angelo O. Rosa, Lars Cleemann, Martin Morad.
Cardiac Signaling Center, MUSC, USC and Clemson University, Charleston,
SC, USA.
Hemoxygenases (HO)-1 and 2 are enzymes that metabolize the heme group,
generating CO, biliverdin and Feþ2. HO-2 is believed to be an O2 sensor in the
carotid body controlling the release of dopamine as it needs O2 for its function.
HO-2 is necessary for the anoxic activation of nociceptive neuron and binds to
calmodulin in neurons, and the complex is modulated by Ca2þ. Previously, we
have found that L-type Ca2þ channel is suppressed by 22-43% with acute an-
oxia prior to metabolic impairment or run down of Ica . This property appeared
to require the calmodulin-binding IQ motif on the cytoplasmic carboxy-tail of
the channel. Here we probe whether HO mediates this rapid Ica-suppressant ef-
fect of anoxia thus serving as the O2 sensor of the heart. Freshly isolated rat
cardiomyocites were maintained in Tyrode containing (in mM): 135NaCl,
5.4KCl, 10Hepes, 10glucose, 1MgCl2 and 2CaCl2). Internal solution used
was (in mM): 15NaCl, 118CsCl, 5.5Glucose, 14EGTA, 3.92CaCl2, 10Hepes,
3MgATP, 0.5MgCl2. Solutions bubbled with 100% O2 or 100% N2 were rap-
idly (50ms) applied. IBa was measured replacing CaCl2 for BaCl2. HO inhibi-
tors ZnPP-IX 100nM or SnPP-IX 100nM were added to either 100% O2 or
100% N2 solutions. Both the O2 removal and the inhibition of HO blocked
692a Wednesday, February 24, 2010about 30% of the ICa and IBa. Administration of anoxic solution did not further
inhibit ICa in cells previously exposed to ZnPP-IX or SnPP-IX. We conclude
that both anoxia and HO suppress ICa and IBa with the same intensity and kinet-
ics and O2 sensing effect becomes negligible in cells exposed to HO inhibitors.
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A New Paradigm for Gem Regulation of Voltage-Gated Ca2þ Channels
Mingming Fan, Jian Yang.
Columbia University, New York, NY, USA.
The RGK (Rem, Rem2, Rad, Gem/Kir) family of Ras-related monomeric small
GTP-binding proteins has emerged as potent inhibitors of high-voltage acti-
vated (HVA) Ca2þ channels. All RGK proteins bind all four subfamilies of
HVA Ca2þ channel b subunits (Cavbs), and Cavb is required for RGK-induced
inhibition. Two modes of RGK action have been reported: (1) RGKs interfere
with channel trafficking to the plasma membrane and hence reduce the number
of surface channels; (2) RGKs inhibit channels already on the plasma mem-
brane. It is generally believed that both forms of inhibition absolutely rely on
the RGK/Cavb interaction. However, this central hypothesis has not been tested
directly. We investigated the molecular mechanism of Gem inhibition of P/Q-
type Ca2þ channels expressed in Xenopus oocytes and HEK 293T cells. Gem
inhibited P/Q channels without affecting their surface expression. Application
of a purified Gem protein domain in inside-out membrane patches acutely in-
hibited P/Q channels. This acute inhibition was completely abolished when
Cavb was removed from surface P/Q channels, but it was fully restored after
the channels regain Cavb. These results unequivocally demonstrate that Cavb
is indispensable for Gem inhibition of surface P/Q channels. Surprisingly, how-
ever, complete disruption of the Gem/Cavb interaction, as shown biochemi-
cally, did not affect Gem inhibition. On the other hand, we discovered that
Gem associated with Cav2.1 in a Cavb-independent manner. Finally, we iden-
tified a 12-amino acid region in the C-terminus of Gem that was sufficient to
produce inhibition in inside-out patches and another site in the core region of
Gem that was also involved in Gem inhibition. Based on these findings, we pro-




The b Subunit of Voltage-Gated Ca2þ Channels Acts as a Transcriptional
Regulator
Yun Zhang, Yoichi Yamada, Mingming Fan, Saroja D. Bangaru,
Bochao Lin, Jian Yang.
Columbia University, New York, NY, USA.
Ca2þ channel b subunits (Cavbs) are essential for the surface expression and
proper gating of high-voltage activated (HVA) Ca2þ channels. In yeast two-hy-
brid screens aimed at discovering novel Cavb-interacting proteins, we identified
a new splicing isoform of Pax6, a transcription factor crucial for the develop-
ment of a variety of organs and tissues, especially the eye. Pax6 contains two
DNA-binding domains (paired domain and homeodomain), a glycine-rich
linker connecting these two domains, and a carboxyl (C)-terminal proline, ser-
ine and threonine (PST)-rich transactivation domain. The newly isolated iso-
forms, named Pax6(S), retains the paired domain, linker and homeodomain
of Pax6, but its C-terminus is composed of a truncated classic PST domain
and a unique S tail. In contrast to Pax6, which is 100% conserved from rodent
to human and is expressed in both embryo and adult, Pax6(S) is completely
conserved only in human and chimpanzee, and it is expressed only at early
stages of development, suggesting that Pax6(S) has a noncanonical function.
Pax6(S) retained strong transcriptional activity, although its C-terminus showed
less transactivity compared with the canonical PST domain. The interaction be-
tween Pax6(S) and Cavb was mainly endowed by the S tail of Pax6(S). Co-ex-
pressionof Pax6(S)with aHVACa2þ channel complex containing theb3 subunit
in Xenopus oocytes did not affect channel properties. However, the transcrip-
tional activity of Pax6(S) was markedly suppressed by b3. Furthermore, in the
presence of Pax6(S), b3 was translocated from the cytoplasm to the nucleus.
These results suggest that full length Cavbs may function as transcription regu-
lators, independent of their role in regulating Ca2þ channel activity.
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Increased Intracellular Magnesium Attenuates b-Adrenergic Stimulation
of the Cardiac Cav1.2 Channel
Sylvain Brunet, Todd Scheuer, William A. Catterall.
University of Washington, Seattle, WA, USA.
Increases in intracellular Mg2þ (Mgi
2þ), as observed in transient cardiac ische-
mia, decrease L-type Ca2þ current of mammalian ventricular myocytes. Tran-sient cardiac ischemia is also associated with an increase in sympathetic tone,
which could stimulate the L-type Ca2þ current. Therefore, the effect of Mgi
2þ
on L-type Ca2þ current in the context of increased sympathetic tone is unclear.
We hypothesized that increased Mgi
2þ in ventricular myocytes might alter the
b-adrenergic stimulation of L-type Ca2þ current. Using the whole-cell patch
clamp method to study ventricular myocytes from C57BL6 mice, we tested
the impact of increased Mgi
2þ on the stimulatory effect of the b-adrenergic re-
ceptor (b-AR) cascade activation on L-type Ca2þ current. We observed that ex-
posure of myocytes to higher Mgi
2þ concentration decreased isoproterenol
stimulation of the L-type Ca2þ current from 75 5 13 % with 0.8 mM Mgi
2þ
(n=11) to 20 5 8 % with 2.4 mM Mgi
2þ (n=7) (p < 0.01). Because Mgi
2þ
could act at multiple sites in the b-AR cascade, we activated this signaling cas-
cade at different steps using pharmacological tools to determine the site(s) of
Mgi
2þ action. We found that exposure of ventricular myocytes to increased
Mgi
2þ attenuated the stimulation of L-type Ca2þ current mediated by isoproter-
enol (b-AR stimulation), forskolin (adenylate cyclase stimulation), and IBMX
(phosphodiesterase inhibition). These experiments rule out significant effects
of Mgi
2þ on the b-AR, Gs protein, adenylate cyclase, and phosphodiesterase
(I-V). Taken together, our results suggest that, in transient ischemia, increased
Mgi
2þ reduces the entry of Ca2þ via the L-type Ca2þ current by directly acting
on the CaV1.2 channel in a cell-autonomous manner, effectively decreasing the
metabolic stress imposed on ventricular myocytes until blood flow can be re-
established.
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Localized Calcineurin in Calcium- Dependent Inactivation of L-type
Calcium Channels
William A. Sather, Seth F. Oliveria, Mark L. Dell’Acqua.
University of Colorado School of Medicine, Aurora, CO, USA.
The open probability of CaV1.2 L-type Ca
2þ channels is enhanced by cAMP-
dependent protein kinase (PKA), which is scaffolded to CaV1.2 channels by A-
kinase anchoring proteins (AKAPs). CaV1.2 channels also undergo negative
autoregulation via Ca2þ-dependent inactivation (CDI). CDI relies upon binding
of Ca2þ/calmodulin (CaM) to an IQ motif in the carboxy tail of CaV1.2 L-type
channels, a mechanism seemingly unrelated to phosphorylation-mediated
channel enhancement. In neurons, AKAP79/150 anchors both PKA and the
Ca2þ-activated phosphatase calcineurin (CaN) to CaV1.2 channels. Using
transfected tsA201 cells or neurons, and tools such as the isolated calcineurin
autoinhibitory peptide, over-expression of the catalytically-inactive CaNH151A
mutant, and RNAi suppression of AKAP79, we have found that channel-linked
CaM serves as a Ca2þ sensor for CaN, and that Ca2þ/CaM-activated CaN par-
ticipates in CDI by reversing channel enhancement by kinases such as PKA.
We have also observed that I/E substitution in the IQ motif produces a mutant
CaV1.2I/EQ channel that - when co-expressed with AKAP79 in tsA201 cells -
unexpectedly exhibits ultra-fast inactivation. Ultra-fast inactivation is elimi-
nated in Ca2þ-free Naþ external solution, as well as by over-expression of
the CaNH151A mutant or stimulation of PKA with forskolin. One interpretation
is that the intact IQ motif’s affinity for Ca2þ/CaM limits the speed of CDI, and
that reducing IQ affinity for Ca2þ/CaM via I/E substitution allows CDI to
proceed at a greatly speeded rate. FRET results with the CaV1.2I/EQ mutant
or with AKAP79 lacking the CaN anchoring motif suggest that, during periods
of elevated channel activity, the IQ-CaM and AKAP79-CaN interactions are
both necessary for CaN-mediated reversal of current enhancement by PKA.
In sum, our work supports a synthetic view fusing previous ideas regarding
CaM and phosphorylation signaling in CDI.
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Sumoylation of Voltage-Gated Alpha1a Calcium Channels
Maria A. Davila1, Haiyan Chen2, Erika S. Piedras-Renteria2.
1Loyola University Chicago, Lakeshore, IL, USA, 2Loyola University
Chicago, Maywood, IL, USA.
The trinucleotide repeat disorder Spinocerebellar ataxia type 6 (SCA6) results
form alterations in the CACNA1A gene coding for the a1A subunit of the neu-
ronal voltage-dependent P/Q-type calcium channel (CaV2.1). We have previ-
ously reported that the a1A subunit is susceptible to proteasomal and lyso-
somal-mediated degradation, and that ubiquitin-mediated degradation is
abnormal in SCA6 a1A, consistent with a glutaminopathy component in
SCA6. The Small Ubiquitin-related Modifier (SUMO) is only distantly related
to ubiquitin (18% homology), but shares many similarities with it, including
a similar protein size, tri-dimensional structure, a C-terminal glycine-glycine
motif for substrate conjugation and many PEST motif-containing substrate tar-
gets. SUMO’s primary functions involve nuclear events and also include
